⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GALT News
Galectin Therapeutics Inc.
Galectin Therapeutics Presented NAVIGATE Trial Results at the American Association for the Study of Liver Diseases (AASLD) 2025 Annual Meeting
globenewswire.com
GALT
Galectin Therapeutics to Present at the American Association for the Study of Liver Disease (AASLD) Liver Meeting 2025
globenewswire.com
GALT